CD4 and neoplasm: High-affinity TCR-modified T cells can detect lower levels of tumor antigens, do not rely on the adjuvant role of CD8 co-receptors, and can produce MHC-1-restricted CD4 T cells to secrete positive cytokines and promote immune initiation [255–257], contributing to the tumor-suppressive milieu and the diversification of TSAs.